FDA Guidance: Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment

Overview:

This document provides guidance to industry on good pharmacovigilance practices and pharmacoepidemiologic assessment, specifically on (1) safety signal identification, (2) pharmacoepidemiologic assessment and safety signal interpretation, and (3) pharmacovigilance plan development.